UAB Comprehensive Cancer Center commemorates signing of new act for cancer screening programs

NewsGuard 100/100 Score

The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center commemorated the signing of legislation requiring the Alabama Department of Public Health to create breast, cervical and colorectal cancer screening programs designed to save the lives of thousands of Alabamians in an event held May 19.

Cancer Center Director Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors, and State Rep. Paul DeMarco (R) of Homewood were featured speakers. Representatives from various cancer organizations, as well as many cancer patients and survivors, were on hand for the commemoration, which included a video of prepared remarks by Gov. Bob Riley. Riley signed the legislation in advance of the event, which he was originally planning to attend; the Gulf oil spill situation dictated a change in the governor's schedule.

The new act, which originated in House Bill 600, gives statutory authority for breast, cervical and colorectal cancer screening programs to the Department of Public Health. Experts say the life-saving practice of expanding proven cancer screening programs benefits everyone, especially the medically under-served and the uninsured.

"We have a responsibility to do the right thing, and this act makes breast, cervical and colorectal cancer prevention and awareness a vital part of our state's anti-cancer policy," Riley said. "Since these forms of the disease are treatable and curable if they're caught early enough, a vital screening program deserves our full support."

Approved by the Alabama Legislature earlier this year, the act also supports raising public awareness about cancer prevention and detection as a responsible and cost-effective health measure. It formalizes the collection and research value of confidential health data gathered on breast, cervical and colorectal cancer prevention and incidence.

"It is tragic when cancer causes the loss of a life, and to me it's completely unnecessary when upward of 70 percent of all cancer deaths can be prevented through screening and early detection," Partridge said, praising the new act and the many academic, legislative, public health, business and nonprofit leaders who advocated for the legislation.

The act was authored by DeMarco after he worked with Partridge, representatives from ACS, the University of South Alabama (USA) Mitchell Cancer Institute and many of those attending the signing ceremony to host the "Alabama Cancer Summit 2009: A Call to Action." The event was held last May at the Birmingham-Jefferson Convention Complex.

DeMarco said it became obvious during last year's summit and through regular discussions with public-health officials that enacting such a law could lead to improved support for these screenings. "I am optimistic this legislation will reduce the state's high cancer death rate," he said.

Data show that an estimated 22,000 new cancer cases occurred in Alabama last year, and that nearly 10,000 Alabamians died from the disease. Experts say those numbers could be reduced by broadening access to cancer screening programs, delivering the message of healthy lifestyle changes and advocating for timely and effective cancer treatment.

During the May 19 commemoration, speakers also kicked off Birmingham's inaugural survivors day event "Celebrating Life" set for June 5 at Pepper Place Saturday Market. A designated National Cancer Survivors Day event, Celebrating Life will take place from 7 a.m. to noon during the Saturday Market at 2829 2nd Ave. South. Riley signed a proclamation in advance declaring June 5 as National Cancer Survivors Day in the state.

SOURCE University of Alabama at Birmingham

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA approval of Anktiva heralds a new era in the treatment of BCG-unresponsive non–muscle-invasive bladder cancer